This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2023.
Company Filing History:
1 out of 12,266 
1 out of 386 
Years Active: 2023
Title: Cathleen Juhl: Innovator in MASP Inhibitory Compounds
Introduction
Cathleen Juhl is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit Mannose-binding lectin (MBL)-associated serine protease (MASP). Her work focuses on innovative solutions for treating and preventing various diseases.
Latest Patents
Cathleen Juhl holds a patent for MASP inhibitory compounds and their uses. The present invention relates to novel MASP inhibitory compounds, as well as analogues and derivatives thereof. It includes processes for the preparation of these compounds and their applications in the treatment and prevention of diseases, especially renal and cardiovascular disorders, as well as ischemia-reperfusion injuries.
Career Highlights
Throughout her career, Cathleen has worked with notable companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations and contribute to significant advancements in medical treatments.
Collaborations
Cathleen has collaborated with esteemed colleagues, including Donald Bierer and Ingo Flamme. These partnerships have enriched her research and expanded the impact of her inventions in the medical field.
Conclusion
Cathleen Juhl's innovative work in MASP inhibitory compounds showcases her dedication to advancing medical science. Her contributions are vital for the development of new treatments for serious health conditions.